Merck’s chronic cough drug gefapixant clears phase 3 testMerck & Co/MSD’s experimental drug gefapixant has improved the frequency of coughing in a pair of phase 3 Share XMerck’s chronic cough drug gefapixant clears phase 3 testhttps://pharmaphorum.com/news/mercks-chronic-cough-drug-gefapixant-clears-phase-3-test/
